Email updates

Keep up to date with the latest news and content from Diagnostic Pathology and BioMed Central.

Open Access Research

Expression of Plakophilins (PKP1, PKP2, and PKP3) in Gastric Cancers

Guzin G Demirag1, Yurdanur Sullu2*, Dilek Gurgenyatagi1, Nilgun O Okumus3 and Idris Yucel1

Author Affiliations

1 Ondokuz Mayis University, Faculty of Medicine, Department of Medical Oncology, Samsun, Turkey

2 Ondokuz Mayis University, Faculty of Medicine, Department of Pathology, Samsun, Turkey

3 Ondokuz Mayis University, Faculty of Medicine, Department of Radiation Oncology, Samsun, Turkey

For all author emails, please log on.

Diagnostic Pathology 2011, 6:1  doi:10.1186/1746-1596-6-1

Published: 2 January 2011

Abstract

Background

The importance of cell-cell junction proteins (including armadillo proteins) in tumor biology is known, but limited with regard to plakophilins. We explored the relationship between plakophilins (PKP1, PKP2, PKP3) to gastric cancer via immunohistochemical techniques.

Methods

We compared the immunohistochemistry of PKPs in 34 gastric adenocarcinomas and 20 normal gastric tissues.

Results

In gastric cancer, PKP1 expression was unchanged but PKP2 and PKP3 were significantly decreased as compared to normal controls. There was no observable clinical association with PKP1 or PKP2 expression; however, low PKP3 level and poor prognosis appeared to correlate with regards to node number and tumor stage. The mean disease-free survival (DFS) was 38 ± 3 months (range: 32 - 44) and mean overall survival (OS) 42 ± 4 months (range: 38 - 50). Decreased PKP2 appeared to negatively impact DFS.

Conclusion

Decreased PKP2 and PKP3 may be early prognostic markers and loss of PKP3 expression during gastric carcinoma progression may indicate an invasive phenotype.